Marking the formal beginning of the evaluation process for Covid-19 vaccine candidates who have applied for emergency clearance in India, the Central Organization for Standard Medicines decided to seek additional safety and efficacy data from the Serum Institute of India and Bharat Biotech before giving the approval. Pfizer’s request was …
Read More »
Written by Kaunain Sheriff M | New Delhi | Updated: December 9, 2020 10:03:07 am At the Serum Institute of India on Monday. (Photo: Reuters) One crore of health workers, two crore of frontline workers, including the police and armed forces, and around 27 crore of people over 50 and …
Read More »
NEW DELHI: A committee of experts from the Central Drug Standard Control Organization (CDSCO) on Wednesday sought additional safety and efficacy data for Covid-19 vaccine candidates from Serum Institute and Bharat Biotech, after deliberating on their applications to obtain an emergency use authorization for injections. official sources said. The request …
Read More »
With safety and efficacy data, Covaxin will be available in the first quarter of 2020, he said. (Archive) Hyderabad: Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing director of Bharat Biotech on Wednesday. “With the safety and efficacy …
Read More »
Written by Kaunain Sheriff M, Amitabh Sinha | New Delhi, Pune | Updated: December 9, 2020 10:02:09 am Vials of Covishield, the Indian version of the AstraZeneca-Oxford vaccine, at the Serum Institute of India in Pune, India. (Reuters photo) Three vaccine developers have submitted applications to the Central Drug Standards …
Read More »
As India approaches a breakthrough in the battle against the COVID-19 pandemic, the Union Health Ministry has reported that some of the vaccine candidates ‘may be licensed’ in the coming weeks. The development comes as three pharmaceutical companies have already applied for Emergency Use Authorization (USA) for their COVID-19 vaccines. …
Read More »
Hopes for an early vaccine for coronavirus disease (Covid-19) in India have been rekindled after three companies, within days of each other, applied for emergency use authorization (USA) of their respective candidate vaccines in the country. While Pfizer Inc of the United States was the first to apply on December …
Read More »
Written by Prabha Raghavan, Anuradha Mascarenhas | New Delhi, Pune | Updated: December 8, 2020 7:15:08 am Hyderabad-based Bharat Biotech has included interim data from early and mid-stage human trials of its Covaxin vaccine candidate. (Archive) In its application for emergency use approval, Hyderabad-based Bharat Biotech has included interim data …
Read More »
NEW DELHI: Hyderabad-based Bharat Biotech submitted an application for an emergency use authorization for Covaxin on Monday, becoming the third company to seek such regulatory approval in India after Pfizer and Serum Institute of India (SII) . Covaxin is the first fully locally developed candidate vaccine against Covid-19 to be …
Read More »
NEW DELHI: Following Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech submitted a request to the central drug regulator on Monday for an emergency use authorization for its Covid-19 Covaxin vaccine, official sources said. Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council for …
Read More »